Saturday, May 10, 2008 10:03:03 PM
JT, QDEL getting ready to go on watch for another bottom play before the run......your thoughts?
Recent QDEL News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 05:03:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:12:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:10:52 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 08:06:23 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 08:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 08:07:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 08:07:20 PM
- Understanding and Addressing Syphilis Trends - and What's Being Missed • PR Newswire (US) • 04/23/2026 01:32:00 PM
- QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics • PR Newswire (US) • 04/20/2026 11:12:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:15:43 PM
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance • PR Newswire (US) • 04/15/2026 08:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 08:40:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 11:00:12 AM
- Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer • PR Newswire (US) • 03/24/2026 11:00:00 AM
- Faster Cardiac Answers with High‑Sensitivity Troponin • PR Newswire (US) • 02/19/2026 02:17:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/19/2026 02:45:21 AM
- QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference • PR Newswire (US) • 02/18/2026 09:05:00 PM
- QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio • PR Newswire (US) • 02/16/2026 06:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 09:21:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:07:04 PM
- QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 02/11/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:19:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:51:39 AM

